SCHEMBL31507774

SCHEMBL31507774

COc1ccc(OCCC(F)(F)C(C)(O)c2ccc(F)cc2)c(F)c1-c1ccn2nc(N)nc2c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 9/20 0.34
▸ PIK3CD O00329 7/20 0.34
▸ PIK3CA P42336 4/20 0.33
▸ NR3C1 P04150 1/20 0.32
▸ PAK4 O96013 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ CSNK1A1 P48729 1/20 0.32
▸ AAK1 Q2M2I8 1/20 0.32
▸ PIP4K2C Q8TBX8 1/20 0.32
▸ CSNK1G1 Q9HCP0 1/20 0.32
▸ RIPK1 Q13546 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ TMEM97 Q5BJF2 1/20 0.31
▸ SIGMAR1 Q99720 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31507818 1.00 PIK3CG (0.34) PIK3CGPIK3CDPIK3CANR3C1PAK4
SCHEMBL31507765 0.93 PIK3CG (0.34) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507709 0.90 PIK3CG (0.33) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507683 0.88 PIK3CG (0.33) PIK3CGPIK3CDPIK3CANR3C1PAK4
SCHEMBL31507748 0.87 PIK3CG (0.35) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507821 0.85 PIK3CG (0.35) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507874 0.85 PIK3CG (0.37) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507634 0.84 PIK3CG (0.34) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507692 0.82 PIK3CG (0.35) PIK3CGPIK3CDPIK3CAPAK4JAK1
SCHEMBL31507776 0.82 PIK3CG (0.35) PIK3CGPIK3CDPIK3CAPAK4JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072392-A1 TRIAZOLOPYRIDINYL ETHER LINKED COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 — — WO disclosed
Send feedback